Dr. Donato is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
92 2nd Street
Hackensack, NJ 07601- Is this information wrong?
Summary
- Dr. Michele Donato is an oncologist in Hackensack, NJ and is affiliated with Hackensack Meridian Health Hackensack University Medical Center. She received her medical degree from McGill University Faculty of Medicine and has been in practice 25 years. She also speaks multiple languages, including French. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hodgkin's lymphoma.
Education & Training
- University of Massachusetts MBA, 2018 - 2022
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1995 - 1997
- McGill University Faculty of MedicineClass of 1992
Certifications & Licensure
- NY State Medical License 2012 - 2026
- NJ State Medical License 2005 - 2025
- DC State Medical License 2004 - 2024
- TX State Medical License 1997 - 2007
- PA State Medical License 1996 - 1998
- American Board of Internal Medicine Medical Oncology
- American Association of Physician LeadersCPE
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer Start of enrollment: 1995 Sep 01
- Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia Start of enrollment: 2010 Apr 12
- Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma Start of enrollment: 2010 Apr 08
- Join now to see all
Publications & Presentations
PubMed
- 109 citationsFludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.Sergio Giralt, Ana Aleman, Athanasios Anagnostopoulos, Donna M. Weber, Issa F. Khouri
Bone Marrow Transplantation. 2002-09-01 - 128 citationsSirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.Daniel R. Couriel, Rima M. Saliba, Maricer P. Escalon, Yvonne Hsu, S. Ghosh
British Journal of Haematology. 2005-08-01 - 194 citationsExtracorporeal photochemotherapy for the treatment of steroid resistant chronic GVHDDaniel R. Couriel, Chitra Hosing, Rima M. Saliba, Elizabeth J. Shpall, Paolo Anderlini
Blood. 2006-04-15
Abstracts/Posters
- Pilot Study of Telmisartan (Micardis) for Prevention of Acute Graft Vs. Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Interim AnalysisMichele L. Donato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 PatientsMichele L. Donato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550)Michele L. Donato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treat...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Bone Marrow Transplant Program Opens at Jersey Shore University Medical CenterAugust 19th, 2022
- 2022 N.J. Top Cancer Doctors Deliver Quality and Compassionate Care, Close to HomeJune 16th, 2022
- Philippines Again Extends COVID-19 Travel Ban on 10 Countries, Including UAE and OmanAugust 13th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- French
Hospital Affiliations
- Hackensack Meridian Health Hackensack University Medical CenterHackensack, New Jersey
- Hackensack Meridian Health Jersey Shore University Medical CenterNeptune, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: